Study of Entry and Continuation in Care for People Living With HIV in French Guiana - Trial NCT05354934

Name: Clinical Trial NCT05354934
Creator: Centre Hospitalier de Cayenne
Keywords: Human Immunodeficiency Virus, quetionnaire, other, clinical trial, French Guiana

Access comprehensive clinical trial information for NCT05354934 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier de Cayenne and is currently Recruiting. The study focuses on Human Immunodeficiency Virus. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

NCT05354934

Recruiting

other

Trial Details

ClinicalTrials.gov • NCT05354934

View on ClinicalTrials.gov

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Study of Entry and Continuation in Care for People Living With HIV in French Guiana

Study Focus

Disease/Condition

Human Immunodeficiency Virus

Drug/Device/Intervention

quetionnaire

Study Type

Observational

Intervention Type

other

Sponsor & Location

Primary Sponsor

Centre Hospitalier de Cayenne

Location

Cayenne, French Guiana

Timeline & Enrollment

Phase

N/A

Start Date

Mar 23, 2022

End Date

Jun 23, 2023

Enrollment

300 participants

Primary Outcome

Identifying factors associated with loss of sight for more than 12 months among people living with HIV in Guyana

Summary

Research Involving the Non-Interventional Human Subject (RIPH category 3). Non-interventional, cross-sectional, multicentre, descriptive and analytical epidemiological study.  A cross-sectional, pseudo-anonymous questionnaire focusing on entry and retention in care will be administered to a sample of PLHIV presenting for consultation in one of the GHT hospitals over a 12-month period.  A sample of 300 PHAs is envisaged to have sufficient power to highlight the main factors associated with periods of loss of sight.  Main objective:  - To identify factors associated with loss of sight for more than 12 months among people living with HIV in Guyana  Secondary objectives:  - To identify factors associated with a delay in the introduction of ARVs among PLHIV in Guyana  - To describe the perception of the quality of the announcement of the diagnosis of HIV  - To describe the difficulties encountered by PLHIV during their hospital follow-up in French Guyana  - To assess the perceived stigma associated with HIV and its consequences in daily life

ICD-10 Classifications

Human immunodeficiency virus [HIV] disease

Unspecified human immunodeficiency virus [HIV] disease

Human immunodeficiency virus [HIV] disease resulting in other conditions

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

Asymptomatic human immunodeficiency virus [HIV] infection status

Data Source

Registry

ClinicalTrials.gov

Trial ID

NCT05354934

Type

Non-Device Trial